Jason Lettmann, Chief Executive Officer at ALX Oncology, will provide opening and closing remarks, highlighting progress and upcoming milestones for the company’s evorpacept clinical program.

In a world where AI and tech are reshaping industries from healthcare to finance, finding the right training can feel like searching for a needle in a digital ...

Company Conference Call and Webcast Information During the virtual company conference call and webcast event for investors, ALX company leadership will review the updated ASPEN-06 data.

--ALX Oncology Holdings Inc.,, a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives, today announced that it will ...

The ALX Oncology virtual R&D Day will be webcast live and a replay will be available after the event by visiting the “Investors” section of ALX Oncology’s website and selecting “Events and ...